 Longeveron Inc NASDAQ: LGVN shares are trading higher Thursday after the company announced the publication of results from a Phase 1 trial testing Lomecel-B on patients with mild Alzheimers disease in Alzheimers Dementia: The Journal of the Alzheimers Association. 